(2004) The Cause of Death Statistics in 2003,

(1999) Cancer statistics,1999,

(2001) A novel approach in the treatment of cancer:targeting the epidermal growth factor receptor, Clin Cancer Res

(2001) Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839(Iressa)a selective epidermal gro wth factor receptor tyrosine kinase inhibitor, Clin Cancer Res

(2002) ZD1839(Iressa)an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy,

(2003) Efficacy of gefitinib an inhibitor of the epidermal growth factor receptor tyrosine kinase in symptomatic patients with non-small cell lung cancer,

(2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer(The IDEAL 1 Trial)[corrected],

(2004) Activating mu tations in the epidermal growth factor receptor under lying responsiveness of non-small-cell lung cancer to gefitinib,

(2003) Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling, Clin Cancer Res

(2001) Tumor suppressor PTEN:modulator of cell signaling,growth,migration and apoptosis,

(1999) PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death,

(1999) Tumor suppressor PTEN inhibition of cell invasion differential involvement of focal adhesion kinase and p130Cas,

(1997) Somatic mutations of PTEN in glio blastoma multiforme,

(2001) Loss of ex pression of the PTEN gene protein product is associated with poor outcome in breast cancer,

(1999) Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage,

(2002) Loss of tumor suppressor protein PTEN during renal carcinogenesis,

(1998) Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias,

(1997) Somatic deletions and mutations in the Cowden disease gene,PTEN,in sporadic thyroid tumors,

(1998) Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers,

(1998) Identifica tion of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines,

(1998) Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma,

(1998) Allelic loss on chromosome 10q in human lung cancer:association with tumour pro gression and metastatic phenotype,

(1998) Mutation analysis of the PTEN/MMAC1 gene in lung cancer,

(1999) Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis,

(2003) Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors,

(2001) Epidermal growth factor rece ptor signaling,